Dr. Reddy’s to acquire Haleon’s global portfolio of consumer healthcare brands in Nicotine Replacement Therapy
Chronic kidney disease market to grow at 19.6 percent CAGR in seven major markets during 2023-33: GlobalData
WHO warns against physical inactivity, says billions of people may end up with these life-threatening disorders
‘Lack of awareness, delayed diagnosis remain challenges in accessing timely treatment of breast cancer’
Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd.
Boy with severe epilepsy becomes world’s first patient to get ‘skull device’—Here’s what you need to know
We are working on reviving its R&D strengths; To launch new products 1-2 months: Rajnish Rohatgi, CEO, Orchid Pharma
FE Mental Health Series | How apps are changing consultation landscape amid drought of experts in India
FE Mental Health Series | India’s troubled minds! How land of 140 crore faces severe shortage of mental health experts
FE Mental Health Series: ‘Three layoffs, divorce, and no support from my family pushed me into depression’
FE Mental Health Series | ‘I lost my very close friend to Postpartum Depression, her death still haunts me’
FE Mental Health Series | You are just sad not depressed; Stop using serious mental health disorders as adjectives
FE Mental Health Series | Beyond spring fans, metal frames—India needs to save its students from suicide epidemic urgently
Zika virus in Pune: Mosquito-borne disease surfaces in western India again! Watch out for these signs, symptoms
Bengaluru Dengue Alert: More than 1000 Dengue cases reported in 20 days—Know all about its symptoms and treatment
Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd. By Sushmita Panda
We are working on reviving its R&D strengths; To launch new products 1-2 months: Rajnish Rohatgi, CEO, Orchid Pharma By Sushmita Panda
There is a lack of awareness among couples regarding fertility treatments: Abhishek Aggrawal, CBO, Birla Fertility and IVF, C.K Birla Group By Sushmita Panda
We are moving into newer disease areas; Xenpozyme will be launched in India soon: Anil Raina, GM, Sanofi Specialty Care, India By Sushmita Panda
Metropolis Healthcare expands its footprint in Africa; Inaugurates Regional Reference Laboratory in Nairobi
We will focus on entering into untapped cities, wellness segment and explore acquisition opportunities: Surendran Chemmenkotil, CEO, Metropolis Healthcare
Lifesciences companies expect more than one-fifth of revenue from connected health in next 5 years: Capgemini report
